Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-13-039326
Filing Date
2013-07-09
Accepted
2013-07-09 19:00:32
Documents
1
Period of Report
2013-07-05

Document Format Files

Seq Description Document Type Size
1 FORM 4 rrd385561.html 4  
1 FORM 4 rrd385561.xml 4 3565
  Complete submission text file 0001181431-13-039326.txt   4797
Mailing Address
Business Address 750 LEXINGTON AVENUE . NEW YORK NY 10022 212-531-5965
KERYX BIOPHARMACEUTICALS INC (Issuer) CIK: 0001114220 (see all company filings)

EIN.: 134087132 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 750 LEXINGTON AVE 20TH FL NEW YORK NY 10022
Business Address
BENTSUR RON (Reporting) CIK: 0001251213 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-30929 | Film No.: 13960478